Comparative Safety and Effectiveness of Biologic Therapy for Crohn’s Disease: A CA-IBD Cohort Study

By sjmartinez • July 25, 2023

Singh S, Kim J, Luo J, Paul P, Rudrapatna V, Park S, Zheng K, Syal G, Ha C, Fleshner P, McGovern D, Sauk JS, Limketkai B, Dulai PS, Boland BS, Eisenstein S, Ramamoorthy S, Melmed G, Mahadevan U, Sandborn WJ, Ohno-Machado L. Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study. Clin Gastroenterol Hepatol. 2023 Aug;21(9):2359-2369.e5. doi: 10.1016/j.cgh.2022.10.029. Epub 2022 Nov 5. PMID: 36343846.

Tags: Biologics, Comparative Effectiveness, Digestive Diseases, Immunosuppressives, Inflammatory Bowel Diseases, Positioning, Publications

JPEN Journal Club 84. Using PICO

Koretz RL. JPEN Journal Club 84. Using PICO. JPEN J Parenter Enteral Nutr. 2024 May 15. doi: 10.1002/jpen.2639. Epub ahead of print. PMID: 38751174.

Sex-dependent interactions between prodromal intestinal inflammation and LRRK2 G2019S in mice promote endophenotypes of Parkinson’s disease

Fang P, Yu LW, Espey H, Agirman G, Kazmi SA, Li K, Deng Y, Lee J, Hrncir H, Romero-Lopez A, Arnold AP, Hsiao EY. Sex-dependent[...]

Role of biomarkers in the diagnosis and management of HCC

Alhasan M, Mehta N, Yang JD, Singal AG. Role of biomarkers in the diagnosis and management of HCC. Liver Transpl. 2024 May 14. doi: 10.1097/LVT.0000000000000398.[...]